Topics
High-grade gliomas | Treatment | Immunotherapy | Interleukins
Home > Publications > Topics > High-grade gliomas > Treatment > Immunotherapy > Interleukins
ElKassar N, Gress RE.
An overview of
IL-7 biology and its use in immunotherapy.
J
Immunotoxicol. 2009 Dec 17;7(1):1-7. doi:
10.3109/15476910903453296. PMID:
20017587. Review. ˍ
Campian JL, Grossman SA, Kask AS, Kosydar S, Strowd R, Piotrowski
A, Tang J, Chheda MG, DiPersio JF, Schullery D, D'Amico L,
Desideri S, Danda N, Ferrando-Martinez S, Lee BH, Fling SP, Ye X.
Phase I study of NT-I7, a long-acting
interleukin-7, in severe treatment-related lymphopenia following
standard radiation and temozolomide for high-grade glioma.
Neurooncol
Adv. 2025 Jun 7;7(1):vdaf117. doi:
10.1093/noajnl/vdaf117. PMID:
40703805. Interventional study. ˍ
AI
Overview